Popular

With big check marks alongside these hurdles, Nuvilex has the potential to become one of biotech’s major players, given its roadmap in the treatment of cancer and diabetes. As a result, the Company’s stock is poised to enjoy a high valuation at a premium to other biotechs.
Read more...
 
Plandaí’s aggressive marketing campaign will reap major benefits as the message that beverages and other products that utilize the Phytofare™ products can provide superior levels of healthy ingredients, such as the polyphenols mentioned above. This differentiation should help the Company expand its market share and generate strong results in 2014.
Read more...
 

It is not uncommon for entrepreneurial or young firms to engage in various strategies or iterations through the lifecycle of the Firm. In some cases, legacy business segments, while smaller or seemingly less important than other, newer initiatives, even if they are profitable, often take a back seat to the new focus of a given company as the new programs likely offer greater potential.

Read more...
 
BLUF: LOI & Thesis Clarification
Our investment thesis that BluForest could become a major player in the sale of verified carbon offsets through reforestation is largely based upon the Company’s balance sheet.
Read more...
 
The Next Major Software Company

Unisource Corp. is well-positioned to emerge as the next major cloud-based software player in the SaaS segment.

Read more...
 

Shares of Plandaí Biotechnology Inc. (OTCQB – PLPL - $0.66 – Spec Buy) closed at a new 52-week high yesterday, despite the current stock market slump. The shares may be further bolstered by results of a research study conducted by The Coca-Cola Company (NYSE – KO).

Read more...
 

When events in progress take longer to complete than originally expected, investors often forget that upcoming events may be as important or even more critical than previous milestones. For longtime investors in Nuvilex, Inc. (OTCQB – NVLX - $0.15 - Spec Buy), so much attention was paid to technology, efficacy, and past clinical trial results that key changes within the Federal Drug Administration (FDA) seem to have gone unnoticed.

Read more...
 

By providing sport and health enthusiasts with high-end guidance and content from experts on their mobile devices at a time of their choosing, users are able to maximize the recreation time in their daily lives through the Company’s apps.

Read more...
 
<< Start < Prev 21 22 23 24 25 26 27 28 29 30 Next > End >>

Page 27 of 39